Oxytocin intranasal (Paratek Pharmaceuticals)

鼻内用缩宫素 (Paratek Pharmaceuticals)

Report date: 2025/05/26 20:01:03

Base Information

Drug NameOxytocin intranasal (Paratek Pharmaceuticals)
Drug Alias NameOptiNose oxytocinOPN-300
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionOxytocin receptor agonists
TargetsOxytocin receptor
Therapy Area/IndicationsAutism Spectrum Disorder
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNorway
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesOptinose As
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOptinose As
Active IndicationsN/A
Inactive IndicationsAutism Spectrum Disorder

Other Information

ATC CodeN/A
Related LinksN/A